KRAS and neoplasm: Likewise, CD44v5-6 and CD44v8-9, but not CD44s, are significantly increased in non-small cell lung adenocarcinoma and mediate tumour cell proliferation and poor prognosis by activating the KRAS/MAPK signalling pathway.